BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15735925)

  • 21. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
    Kim S; Chung JK; Im SH; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):52-9. PubMed ID: 15309332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
    Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
    J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma.
    Ullrich RT; Kracht L; Brunn A; Herholz K; Frommolt P; Miletic H; Deckert M; Heiss WD; Jacobs AH
    J Nucl Med; 2009 Dec; 50(12):1962-8. PubMed ID: 19910435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
    Ribom D; Smits A
    Neurol Res; 2005 Jul; 27(5):516-21. PubMed ID: 15978178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
    Morana G; Piccardo A; Puntoni M; Nozza P; Cama A; Raso A; Mascelli S; Massollo M; Milanaccio C; Garrè ML; Rossi A
    Neuro Oncol; 2015 Dec; 17(12):1637-47. PubMed ID: 26405202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utility of 11C-methionine PET/CT in neuro-oncology].
    Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
    Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET using 11C-methionine in recognition of pseudoprogression in cerebral glioma after combined treatment.
    Skvortsova TY; Brodskaya ZL; Gurchin AF
    Zh Vopr Neirokhir Im N N Burdenko; 2014; 78(4):50-8. PubMed ID: 25406809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
    Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography with injection of methionine as a prognostic factor in glioma.
    De Witte O; Goldberg I; Wikler D; Rorive S; Damhaut P; Monclus M; Salmon I; Brotchi J; Goldman S
    J Neurosurg; 2001 Nov; 95(5):746-50. PubMed ID: 11702862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.
    Würker M; Herholz K; Voges J; Pietrzyk U; Treuer H; Bauer B; Sturm V; Heiss WD
    Eur J Nucl Med; 1996 May; 23(5):583-6. PubMed ID: 8698067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.
    Singhal T; Narayanan TK; Jacobs MP; Bal C; Mantil JC
    J Nucl Med; 2012 Nov; 53(11):1709-15. PubMed ID: 23055534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
    Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E
    Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential diagnosis of brain gliomas by positron emission tomography using various radiopharmaceuticals].
    Kostenikov NA; Tiutin LA; Fadeev NP; Panfilenko AF; Zykov EM; Iliushchenko IuR; Makeeva OIu
    Vestn Rentgenol Radiol; 2014; (5):13-8. PubMed ID: 25775890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma.
    Nariai T; Tanaka Y; Wakimoto H; Aoyagi M; Tamaki M; Ishiwata K; Senda M; Ishii K; Hirakawa K; Ohno K
    J Neurosurg; 2005 Sep; 103(3):498-507. PubMed ID: 16235683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.